Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.060
-0.060 (-5.36%)
At close: Dec 5, 2025, 4:00 PM EST
1.050
-0.010 (-0.93%)
After-hours: Dec 5, 2025, 7:36 PM EST

Lexaria Bioscience Revenue

In the fiscal year ending August 31, 2025, Lexaria Bioscience had annual revenue of $705.92K with 52.05% growth. Lexaria Bioscience had revenue of $174.00K in the quarter ending August 31, 2025, with 107.14% growth.

Revenue (ttm)
$705.92K
Revenue Growth
+52.05%
P/S Ratio
28.56
Revenue / Employee
$100,846
Employees
7
Market Cap
23.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2025705.92K241.65K52.05%
Aug 31, 2024464.28K238.07K105.24%
Aug 31, 2023226.21K-29.19K-11.43%
Aug 31, 2022255.40K-467.34K-64.66%
Aug 31, 2021722.74K407.95K129.59%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

LEXX News

More News